INKT
Price
$0.52
Change
-$0.02 (-3.70%)
Updated
Dec 18, 04:09 PM (EDT)
91 days until earnings call
VINC
Price
$0.21
Change
+$0.02 (+10.53%)
Updated
Dec 18, 04:35 PM (EDT)
104 days until earnings call
Ad is loading...

INKT vs VINC

Header iconINKT vs VINC Comparison
Open Charts INKT vs VINCBanner chart's image
MiNK Therapeutics
Price$0.52
Change-$0.02 (-3.70%)
Volume$100
CapitalizationN/A
Vincerx Pharma
Price$0.21
Change+$0.02 (+10.53%)
Volume$13.12K
CapitalizationN/A
INKT vs VINC Comparison Chart
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. VINC commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a StrongBuy and VINC is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (INKT: $0.54 vs. VINC: $0.19)
Brand notoriety: INKT and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 306% vs. VINC: 78%
Market capitalization -- INKT: $21.31M vs. VINC: $6.46M
INKT [@Biotechnology] is valued at $21.31M. VINC’s [@Biotechnology] market capitalization is $6.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, VINC is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 4 TA indicator(s) are bullish while VINC’s TA Score has 5 bullish TA indicator(s).

  • INKT’s TA Score: 4 bullish, 6 bearish.
  • VINC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VINC is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а -18.64% price change this week, while VINC (@Biotechnology) price change was -10.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

INKT is expected to report earnings on Mar 19, 2025.

VINC is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($21.3M) has a higher market cap than VINC($6.46M). INKT YTD gains are higher at: -49.654 vs. VINC (-83.729). INKT has higher annual earnings (EBITDA): -14.07M vs. VINC (-27.1M). VINC has more cash in the bank: 10.1M vs. INKT (6.33M). VINC has less debt than INKT: VINC (1.64M) vs INKT (4.61M). INKT (0) and VINC (0) have equivalent revenues.
INKTVINCINKT / VINC
Capitalization21.3M6.46M330%
EBITDA-14.07M-27.1M52%
Gain YTD-49.654-83.72959%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.33M10.1M63%
Total Debt4.61M1.64M281%
TECHNICAL ANALYSIS
Technical Analysis
INKTVINC
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 23 days ago
80%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRN67.191.65
+2.52%
BioMarin Pharmaceutical
SDA8.840.08
+0.91%
SunCar Technology Group
SBFM2.740.02
+0.74%
Sunshine Biopharma Inc
FL22.26-0.23
-1.02%
Foot Locker
SFWL1.05-0.02
-1.87%
Shengfeng Development Limited

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with CADL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-7.12%
CADL - INKT
41%
Loosely correlated
+7.23%
VINC - INKT
39%
Loosely correlated
-0.31%
NKTR - INKT
34%
Loosely correlated
+2.00%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
-2.58%
More

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with INKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-0.31%
INKT - VINC
39%
Loosely correlated
-7.12%
APVO - VINC
33%
Loosely correlated
+8.25%
RNA - VINC
31%
Poorly correlated
-1.95%
VNDA - VINC
30%
Poorly correlated
+2.16%
IOVA - VINC
30%
Poorly correlated
-0.38%
More